# An Observational Study on Teriflunomide-exposed Pregnancies

> **NCT03198351** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 220 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Teriflunomide (HMR1726)

## Key facts

- **NCT ID:** NCT03198351
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-25
- **Primary completion:** 2023-06-13
- **Final completion:** 2023-06-13
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198351, "An Observational Study on Teriflunomide-exposed Pregnancies". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03198351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*